| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President &CEO | Interim CEO
2 companies
Quinn Anthony G. is a President &CEO at Spyre Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $42.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2017 | SYRE Spyre Therapeutics, Inc. | Interim CEO | Buy | 8,288 | $4.96 | $41,078.38 | +8.8% | |
| Dec 5, 2017 | SYRE Spyre Therapeutics, Inc. | Director | Buy | 17,121 | $4.86 | $83,177.50 | +37.1% | |
| Apr 12, 2016 | SYRE Spyre Therapeutics, Inc. | Director | Buy | 10,000 | $10.00 | $100,000.00 | New |